Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-24-008424
Filing Date
2024-02-16
Accepted
2024-02-16 19:15:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A ef20021932_sc13ga.htm SC 13G/A 56200
  Complete submission text file 0001140361-24-008424.txt   57660
Mailing Address C/O BRIDGEBIO PHARMA, INC. 3160 PORTER DR, STE 250 PALO ALTO CA 94304
Business Address
Kumar Neil (Filed by) CIK: 0001742485 (see all company filings)

Type: SC 13G/A

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Subject) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91059 | Film No.: 24650125
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)